Home / Recalls / Abbott Laboratories, Inc / Z-1987-2019

Z-1987-2019 Class II Terminated

Recalled by Abbott Laboratories, Inc — Irving, TX

FDA device recall Z-1987-2019 was initiated by Abbott Laboratories, Inc on May 16, 2018 and is designated Class II. Reason for recall: An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products. The recall status is terminated (terminated Aug 16, 2021). Affected quantity: 8,132 kits.

Recall Details

Product Type: Devices
Report Date: Jul 31, 2019
Initiation Date: May 16, 2018
Termination Date: Aug 16, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 8,132 kits

Product Description

C3 is an in vitro diagnostic assay for the quantitative determination of C3 in human serum or plasma. Antibodies to C3 combine with C3 in the sample to form insoluble immune complexes. The immune complexes cause an increase in light scattering (turbidity). The resulting increase in sample turbidity, measured at 604 nm, is directly proportional to the concentration of C3 in the sample.

Reason for Recall

An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products.

Distribution Pattern

Distribution was nationwide, including Puerto Rico. There was government/military distribution. Foreign distribution was made to Canada, Albania, Algeria, Andorra, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovi, Botswana, Brazil, Brunei, Bulgaria, Chile, China, Costa Rica, Croatia, Curacao (Netherlands Antilles), Cyprus, Czech Republic, Democratic Republic of the Congo, Denmark, Ecuador, Egypt, Estonia, Finland, France, Gaza & Jericho, Germany, Greece, Greenland, Honduras, Hong Kong, India, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Jordan, Kazakhstan, Kenya, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya. Lithuania, Luxembourg, Macedonia, Malaysia, Maldives, Mali, Mauritania, Mexico, Moldova, Montenegro, Morocco, Namibia, Netherlands, New Zealand, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Yemen, Romania, Russia, Rwanda, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Tanzania, Thailand, Trinidad & Tobago, Tunisia, Turkey, Turks and Caicos, Tunisia, UAE, United Kingdom, Uruguay, and Viet Nam.

Code Information

All IFU's

Source

Dataset: openFDA device recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for Z-1987-2019
openFDA file date: Oct 23, 2026
Loaded by RegDataLab: Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Abbott Laboratories, Inc

Z-0961-2026 Class II — Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20 (Nov 13, 2025)
Z-0489-2026 Class II — Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer… (Sep 18, 2025)
Z-1652-2025 Class II — Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number… (Mar 18, 2025)
Z-1653-2025 Class II — Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number… (Mar 18, 2025)
Z-1656-2025 Class II — Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number… (Mar 18, 2025)
Z-1655-2025 Class II — Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number… (Mar 18, 2025)
Z-1654-2025 Class II — Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number… (Mar 18, 2025)
Z-2681-2024 Class II — Alinity hq Analyzer, REF: 09P68-01 (Jun 14, 2024)
Z-1476-2024 Class II — ARCHITECT STAT Myoglobin Reagent Kit, LN 2K43-25 and 2K43-20. (Feb 21, 2024)
F-0328-2024 Class II — Similac Probiotic Tri-Blend - 0.017oz (0.50g) packaged in foil packets. 50 foil… (Oct 31, 2023)